Relationship between diversity of hepatitis C quasispecies and histological severity of liver disease

Medicina

Volumn 60, Issue 5, 2000, Pages 587-590

  Sookoian, Silvia ^a,b   Flichman, Diego ^a   Castaño, Gustavo ^a   Frider, Bernardo ^a   Campos, Rodolfo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

HCV infection; HCV variability; HCV heterogeneity; HCV quasispecies; Hepatitis C; SSCP HCV

Indexed keywords

RNA; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; FEMALE; GENETIC VARIABILITY; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SPECIES DIFFERENCE; VIROLOGY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA; SPECIES SPECIFICITY; VARIATION (GENETICS);

EID: 0034577163     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 1906-11.
2. Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225-9.
3. Domingo E, Martinez-Salas E, Sobrino F, et al. The quasispecies (extremely hererogeneous) nature of viral RNA genome populations: biological relevance - a review. Gene 1985; 40: 1-8.
4. Kanazawa Y, Hayashi N, Mita E, Li T, et al. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 1994; 20: 1121-30.
5. Farci P, Bukh J, Purcell RH. The quasispecies of hepatitis C virus and the host immune response. Springer Semin Immunopathol 1997; 19: 5-26.
6. Hopf U, Moller B, Kuther D, et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990; 10: 69-76.
7. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-6.
8. Seeff LB. Natural history of hepatitis C. Hepatology 1997; 26:21S-28S.
9. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899-905.
10. Knodell KG, Ishack KG, Black WC, et al. Formulation and application of a numeric scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
11. Chomczynski SP, Sacchi N Single step method of RNA isolation by guanidinum thiocyanate-phenol-chloroform extraction. Analyt Biochem 1987; 162: 156-9.
12. Koizumi K, Enamoto N, Kurosaki M et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995; 22: 30-5.
13. Leone F, Zylberberg H, Squadrito G, et al. Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection. J Hepatol 1998, 29: 689-94.